Jazz Pharmaceuticals (JAZZ) Divestments (2015)
Jazz Pharmaceuticals' quarterly Divestments came in at $1.0 million in Q2 2015, down 96.97% quarter-over-quarter from $33.0 million in Q1 2015.
Jazz Pharmaceuticals has reported Divestments for 1 years, with the latest figure at $1.0 million in Q2 2015.
- For the quarter ending Q2 2015, Divestments changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2016 stood at $1.0 million (down 96.97% YoY), and the FY2022 full-year result was $53.0 million, changed N/A from the prior year.
- Divestments for Q2 2015 stood at $1.0 million, down from $33.0 million in the prior quarter.
- The five-year high for Divestments was $33.0 million in Q1 2015, with the low at $1.0 million in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.00 Mn |
| Mar 31, 2015 | 33.00 Mn |